Leviathan Cannabis Group Inc Share Price Canadian Securities Exchange
Equities
CA61762Y1051
Pharmaceuticals
Sales 2022 | 842K 619K 48.74M | Sales 2023 | 35.34M 25.95M 2.04B | Capitalization | 219M 160M 12.64B |
---|---|---|---|---|---|
Net income 2022 | -4M -2.94M -231M | Net income 2023 | - 0 0 | EV / Sales 2022 | 150 x |
Net Debt 2022 | 8.9M 6.53M 515M | Net Debt 2023 | 3.32M 2.43M 192M | EV / Sales 2023 | 6.28 x |
P/E ratio 2022 |
-23.4
x | P/E ratio 2023 |
-238
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.12% |
Managers | Title | Age | Since |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 06/03/22 |
Director of Finance/CFO | - | 06/03/22 | |
Kamyar Hosseini
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 06/03/22 |
Rupalee Mehta
BRD | Director/Board Member | - | 06/03/22 |
Lucas Leone
BRD | Director/Board Member | - | 06/03/22 |
1st Jan change | Capi. | |
---|---|---|
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |